首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Hepatology International

Hepatology International杂志,由Springer India出版,于2007年创刊,Quarterly,出版语言English,ISSN:1936-0533,E-ISSN:1936-0541。

投稿咨询
Hepatology International
Hepatology International
Hepatology International
SCI SCIE

杂志介绍

JCR分区
Q1
中科院分区
2区
影响因子
7.8
CiteScore
12.3
期刊收录
SCI、SCIE

Hepatology International(中文译名:《国际肝病学》),ISSN:1936-0533,EISSN:1936-0541,是Springer India出版的国际性学术期刊,创刊于2007年,以Quarterly形式稳定发行,2026年总发文量约97篇。该刊采用非OA开放访问,学科归属为医学 - 胃肠肝病学。该刊是医学、胃肠肝病学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达7.8,2025年期刊CiteScore为12.3,2025年期刊自引率约3.8%,在中科院期刊分区体系中位列医学大类2区TOP 期刊,在所属学科领域具备高学术影响力与国际认可度。Hepatology International长期聚焦医学、胃肠肝病学及相关产业的技术应用前沿,平均审稿周期较慢,6-12周,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、胃肠肝病学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,CHINA MAINLANDUSA、India、Japan、South Korea、Taiwan、England等为核心发文国家与地区;INSTITUTE OF LIVER & BILIARY SCIENCES (ILBS)CAPITAL MEDICAL UNIVERSITY、HUAZHONG UNIVERSITY OF SCIENCE & TECHNOLOGY、CHINESE PEOPLE'S LIBERATION ARMY GENERAL HOSPITAL、PEKING UNIVERSITY、UNIVERSITY OF HONG KONG、FUDAN UNIVERSITY等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
2区
GASTROENTEROLOGY & HEPATOLOGY 胃肠肝病学
2区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
1区
GASTROENTEROLOGY & HEPATOLOGY 胃肠肝病学
2区

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
2区
GASTROENTEROLOGY & HEPATOLOGY 胃肠肝病学
3区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:GASTROENTEROLOGY & HEPATOLOGY SCIE Q1 19 / 153

87.9

学科:GASTROENTEROLOGY & HEPATOLOGY SCIE Q1 18 / 153

88.56

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:GASTROENTEROLOGY & HEPATOLOGY SCIE Q1 20 / 148

86.8

学科:GASTROENTEROLOGY & HEPATOLOGY SCIE Q1 18 / 148

88.18


中国学者近期发文

1
FXR overexpression promotes liver regeneration through inducing FGF2 activation in APAP-induced acute liver injur

Author:Wang, Rui; Chen, Jiaqi; Wang, Wenyu; Li, Xia; Xiao, Yating; Shi, Yubo; Qv, Yifan; Wang, Changyuan; Fu, Ting; Meng, Qiang

Journal: HEPATOLOGY INTERNATIONAL. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s12072-026-11078-4

2
Distinct amino acid metabolic subtypes predict prognosis and stratify treatment response in acute-on-chronic liver failure: a multicenter prospective stud

Author:Zheng, Haocheng; Yu, Simiao; Zhou, Ting; Fu, Shuangnan; Zhang, Jingjing; Zhang, Ning; Liu, Yijiang; Huang, Yanyang; He, Zhaoyun; Zhang, Jin; Liu, Pengcheng; Gong, Man; Zhou, Chao

Journal: HEPATOLOGY INTERNATIONAL. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s12072-026-11077-5

3
Re-examining the incremental benefit of TACE-TKI-PD-1 triplet therapy: time-related bias and treatment pathways in a real-world HCC cohor

Author:Zhang, Yuanqin; He, Yang; Chen, Yifei; Nie, Fang

Journal: HEPATOLOGY INTERNATIONAL. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s12072-026-11080-w

4
Methodological and safety considerations for combination immunotherapy and NA cessation in CH

Author:Han, Jing; Qiang, Di; Qiu, Shasha; Lou, Liming

Journal: HEPATOLOGY INTERNATIONAL. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s12072-026-11081-9

5
Feasibility and cost-effectiveness of a hospital-based hepatitis B management model in China: the 'Hot Wave Project' experienc

Author:Luo, Qiumin; Chen, Jia; Liu, Hanting; Zhang, Yeqiong; Shi, Wenqi; Xie, Chan; Gao, Zhiliang; Liu, Zifeng; Li, Jinghua; Peng, Liang

Journal: HEPATOLOGY INTERNATIONAL. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s12072-026-11083-7

6
Phase-specific polarization of peripheral helper T cells influences immunopathology and viral control in HBV infectio

Author:Li, Xiao-Yu; Zhang, Peng; Zhu, Mengmeng; Lv, Qiaolan; Li, Jing; Zhang, Xiangyan; Cheng, Yongqian; Meng, Fanping; Zhang, Min; Zhou, Ming-Ju; Wang, You-Yuan; Yu, Yingying; Feng, Jin; Chen, Si-Yuan; Wang, Ming-Li; Jiao, Yan-Mei; Fan, Xing; Song, Jin-Wen; Xu, Ruonan; Zhen, Cheng; Shi, Ming; Wang, Fu-Sheng; Zhang, Chao

Journal: HEPATOLOGY INTERNATIONAL. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s12072-026-11082-8

7
Comment on Metabolic dysfunction-associated steatotic liver disease and adverse pregnancy outcomes: a nationwide cohort stud

Author:Xu, Qiongying; Han, Jiehua; Zhu, Jiali

Journal: HEPATOLOGY INTERNATIONAL. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s12072-025-11026-8

8
Comment on Autoimmune liver diseases in the Asia Pacific region: proceedings of the autoimmune liver disease course at APASL 202

Author:Wu, Bin

Journal: HEPATOLOGY INTERNATIONAL. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s12072-026-11054-y

9
Beyond association: rethinking diabetes in alcohol-related acute-on-chronic liver failur

Author:Chai, Yinying; Qiu, Shengliang

Journal: HEPATOLOGY INTERNATIONAL. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s12072-025-11031-x

10
Comment on Inhibition of the U12-type splicing factor ZCRB1 mediates retention of the USP21 minor intron to suppress malignant progression in hepatocellular carcinom

Author:Xu, Qiongying; Han, Jiehua; Zhu, Jiali

Journal: HEPATOLOGY INTERNATIONAL. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s12072-026-11056-w


在线咨询

Hepatology International

国际简称:HEPATOL INT参考译名:国际肝病学

年发文量:97 CiteScore:12.3 是否预警:否 Gold OA文章占比:31.15% 研究类文章占比:81.44%

杂志社联系方式:SPRINGER, 233 SPRING ST, NEW YORK, USA, NY, 10013

Hepatology International